Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Collegium Pharmaceutical Inc shares valued at $671,576 were sold by Smith Thomas B on Aug 29 ’25. At $38.42 per share, Smith Thomas B sold 17,478 shares. The insider’s holdings dropped to 70,264 shares worth approximately $2.43 million following the completion of this transaction.
Also, Smith Thomas B purchased 17,478 shares, netting a total of over 671,576 in proceeds.
Before that, Dreyer Scott had sold 16,389 shares from its account. In a trade valued at $626,171, the EVP & Chief Commercial Officer traded Collegium Pharmaceutical Inc shares for $38.21 each. Upon closing the transaction, the insider’s holdings decreased to 16,389 shares, worth approximately $3.59 million.
As published in a research note from Needham on January 10, 2025, Collegium Pharmaceutical Inc [COLL] has been rated up from a Hold to a Buy and the price target has been revised to $46. Analysts at H.C. Wainwright upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late July. As of June 07, 2024, Jefferies has increased its “Hold” rating to a “Buy” for COLL. Earlier on May 10, 2024, Piper Sandler downgraded its rating. Their new recommendation was “a Neutral” for COLL stock which previously was a “an Overweight”.
Analyzing COLL Stock Performance
On last trading session, Collegium Pharmaceutical Inc [NASDAQ: COLL] plunged -1.45% to $34.65. The stock’s lowest price that day was $34.335, but it reached a high of $36.29 in the same session. During the last five days, there has been a drop of approximately -4.18%. Over the course of the year, Collegium Pharmaceutical Inc shares have dropped approximately -9.32%. Shares of the company reached a 52-week high of $39.95 on 08/22/25 and a 52-week low of $23.23 on 04/10/25.
Support And Resistance Levels for Collegium Pharmaceutical Inc (COLL)
According to the 24-hour chart, there is a support level at 33.89, which, if violated, would cause prices to drop to 33.14. In the upper region, resistance lies at 35.85. The next price resistance is at 37.05. RSI (Relative Strength Index) is 40.22 on the 14-day chart, showing neutral technical sentiment.
Is Collegium Pharmaceutical Inc subject to short interest?
Stocks of Collegium Pharmaceutical Inc saw a sharp rise in short interest on 2025-08-29 jumping by 0.11 million shares to 4.32 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 4.22 million shares. A jump of 2.52% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 10.26 of the overall float, the days-to-cover ratio (short ratio) jumped to 10.26.
Which companies own the most shares of Collegium Pharmaceutical Inc (COLL)?
In terms of Collegium Pharmaceutical Inc share price expectations, FactSet research, analysts set an average price target of 38 in the next 12 months, up nearly 8.08% from the previous closing price of $35.16. Analysts anticipate Collegium Pharmaceutical Inc stock to reach 50 by 2025, with the lowest price target being 35. In spite of this, 4 analysts ranked Collegium Pharmaceutical Inc stock as Buy at the end of 2025.
